nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophenazone—CYP17A1—Dexamethasone—multiple sclerosis	0.286	0.315	CbGbCtD
Aminophenazone—CYP2D6—Fingolimod—multiple sclerosis	0.0911	0.1	CbGbCtD
Aminophenazone—CYP3A4—Fingolimod—multiple sclerosis	0.0579	0.0637	CbGbCtD
Aminophenazone—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0483	0.0531	CbGbCtD
Aminophenazone—CYP3A7—Dexamethasone—multiple sclerosis	0.0483	0.0531	CbGbCtD
Aminophenazone—CYP2C19—Prednisone—multiple sclerosis	0.0468	0.0514	CbGbCtD
Aminophenazone—SLC22A6—Methotrexate—multiple sclerosis	0.0425	0.0467	CbGbCtD
Aminophenazone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0373	0.0411	CbGbCtD
Aminophenazone—CYP2C8—Dexamethasone—multiple sclerosis	0.0348	0.0383	CbGbCtD
Aminophenazone—CYP2C19—Dexamethasone—multiple sclerosis	0.0292	0.0321	CbGbCtD
Aminophenazone—CYP3A4—Triamcinolone—multiple sclerosis	0.0283	0.0311	CbGbCtD
Aminophenazone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0272	0.0299	CbGbCtD
Aminophenazone—CYP2C9—Dexamethasone—multiple sclerosis	0.0243	0.0267	CbGbCtD
Aminophenazone—CYP3A4—Betamethasone—multiple sclerosis	0.0243	0.0267	CbGbCtD
Aminophenazone—CYP3A4—Prednisolone—multiple sclerosis	0.0239	0.0263	CbGbCtD
Aminophenazone—CYP3A4—Prednisone—multiple sclerosis	0.0226	0.0249	CbGbCtD
Aminophenazone—CYP2D6—Dexamethasone—multiple sclerosis	0.0222	0.0244	CbGbCtD
Aminophenazone—CYP3A4—Dexamethasone—multiple sclerosis	0.0141	0.0155	CbGbCtD
Aminophenazone—CYP17A1—Endogenous sterols—POMC—multiple sclerosis	0.000982	0.0108	CbGpPWpGaD
Aminophenazone—CYP17A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000873	0.00963	CbGpPWpGaD
Aminophenazone—CYP17A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000873	0.00963	CbGpPWpGaD
Aminophenazone—CYP3A7—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000864	0.00953	CbGpPWpGaD
Aminophenazone—CYP3A7—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000864	0.00953	CbGpPWpGaD
Aminophenazone—CYP17A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000861	0.00949	CbGpPWpGaD
Aminophenazone—CYP17A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000861	0.00949	CbGpPWpGaD
Aminophenazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000856	0.00944	CbGpPWpGaD
Aminophenazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000856	0.00944	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.000735	0.00811	CbGpPWpGaD
Aminophenazone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000731	0.00807	CbGpPWpGaD
Aminophenazone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000731	0.00807	CbGpPWpGaD
Aminophenazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000709	0.00782	CbGpPWpGaD
Aminophenazone—CYP2C18—Biological oxidations—CYP24A1—multiple sclerosis	0.000691	0.00762	CbGpPWpGaD
Aminophenazone—CYP2C18—Biological oxidations—CYP27B1—multiple sclerosis	0.000691	0.00762	CbGpPWpGaD
Aminophenazone—CYP2C18—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000681	0.00751	CbGpPWpGaD
Aminophenazone—CYP2C18—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000681	0.00751	CbGpPWpGaD
Aminophenazone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000667	0.00736	CbGpPWpGaD
Aminophenazone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000667	0.00736	CbGpPWpGaD
Aminophenazone—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000659	0.00727	CbGpPWpGaD
Aminophenazone—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000659	0.00727	CbGpPWpGaD
Aminophenazone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000596	0.00657	CbGpPWpGaD
Aminophenazone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000596	0.00657	CbGpPWpGaD
Aminophenazone—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000588	0.00649	CbGpPWpGaD
Aminophenazone—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000588	0.00649	CbGpPWpGaD
Aminophenazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000564	0.00623	CbGpPWpGaD
Aminophenazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000564	0.00623	CbGpPWpGaD
Aminophenazone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000548	0.00604	CbGpPWpGaD
Aminophenazone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000548	0.00604	CbGpPWpGaD
Aminophenazone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000543	0.00599	CbGpPWpGaD
Aminophenazone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000543	0.00599	CbGpPWpGaD
Aminophenazone—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000541	0.00597	CbGpPWpGaD
Aminophenazone—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000541	0.00597	CbGpPWpGaD
Aminophenazone—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000541	0.00597	CbGpPWpGaD
Aminophenazone—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000541	0.00597	CbGpPWpGaD
Aminophenazone—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000536	0.00591	CbGpPWpGaD
Aminophenazone—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000536	0.00591	CbGpPWpGaD
Aminophenazone—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.0005	0.00551	CbGpPWpGaD
Aminophenazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000495	0.00546	CbGpPWpGaD
Aminophenazone—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000483	0.00533	CbGpPWpGaD
Aminophenazone—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000483	0.00533	CbGpPWpGaD
Aminophenazone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000464	0.00512	CbGpPWpGaD
Aminophenazone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000464	0.00512	CbGpPWpGaD
Aminophenazone—CYP3A7—Biological oxidations—CYP24A1—multiple sclerosis	0.000459	0.00506	CbGpPWpGaD
Aminophenazone—CYP3A7—Biological oxidations—CYP27B1—multiple sclerosis	0.000459	0.00506	CbGpPWpGaD
Aminophenazone—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000458	0.00505	CbGpPWpGaD
Aminophenazone—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000458	0.00505	CbGpPWpGaD
Aminophenazone—CYP17A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000456	0.00503	CbGpPWpGaD
Aminophenazone—CYP3A7—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000453	0.00499	CbGpPWpGaD
Aminophenazone—CYP3A7—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000453	0.00499	CbGpPWpGaD
Aminophenazone—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000444	0.0049	CbGpPWpGaD
Aminophenazone—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000444	0.0049	CbGpPWpGaD
Aminophenazone—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00044	0.00486	CbGpPWpGaD
Aminophenazone—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00044	0.00486	CbGpPWpGaD
Aminophenazone—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000425	0.00469	CbGpPWpGaD
Aminophenazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000398	0.00439	CbGpPWpGaD
Aminophenazone—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000376	0.00415	CbGpPWpGaD
Aminophenazone—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000376	0.00415	CbGpPWpGaD
Aminophenazone—CYP17A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00037	0.00408	CbGpPWpGaD
Aminophenazone—CYP2C18—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000361	0.00398	CbGpPWpGaD
Aminophenazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000358	0.00395	CbGpPWpGaD
Aminophenazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000358	0.00395	CbGpPWpGaD
Aminophenazone—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000354	0.0039	CbGpPWpGaD
Aminophenazone—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000354	0.0039	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000335	0.0037	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000335	0.0037	CbGpPWpGaD
Aminophenazone—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000322	0.00355	CbGpPWpGaD
Aminophenazone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000321	0.00355	CbGpPWpGaD
Aminophenazone—CYP2C18—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000292	0.00323	CbGpPWpGaD
Aminophenazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00029	0.0032	CbGpPWpGaD
Aminophenazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00029	0.0032	CbGpPWpGaD
Aminophenazone—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000287	0.00317	CbGpPWpGaD
Aminophenazone—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000287	0.00317	CbGpPWpGaD
Aminophenazone—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000283	0.00313	CbGpPWpGaD
Aminophenazone—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000283	0.00313	CbGpPWpGaD
Aminophenazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00028	0.00309	CbGpPWpGaD
Aminophenazone—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000279	0.00308	CbGpPWpGaD
Aminophenazone—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000257	0.00283	CbGpPWpGaD
Aminophenazone—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000257	0.00283	CbGpPWpGaD
Aminophenazone—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000257	0.00283	CbGpPWpGaD
Aminophenazone—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000253	0.00279	CbGpPWpGaD
Aminophenazone—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000253	0.00279	CbGpPWpGaD
Aminophenazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.00025	0.00276	CbGpPWpGaD
Aminophenazone—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00024	0.00265	CbGpPWpGaD
Aminophenazone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000239	0.00264	CbGpPWpGaD
Aminophenazone—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000236	0.0026	CbGpPWpGaD
Aminophenazone—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000236	0.0026	CbGpPWpGaD
Aminophenazone—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000234	0.00258	CbGpPWpGaD
Aminophenazone—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000234	0.00258	CbGpPWpGaD
Aminophenazone—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000233	0.00257	CbGpPWpGaD
Aminophenazone—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000233	0.00257	CbGpPWpGaD
Aminophenazone—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000231	0.00254	CbGpPWpGaD
Aminophenazone—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000231	0.00254	CbGpPWpGaD
Aminophenazone—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000225	0.00248	CbGpPWpGaD
Aminophenazone—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000221	0.00244	CbGpPWpGaD
Aminophenazone—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000217	0.0024	CbGpPWpGaD
Aminophenazone—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000216	0.00238	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism—SRM—multiple sclerosis	0.000212	0.00234	CbGpPWpGaD
Aminophenazone—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.0002	0.00221	CbGpPWpGaD
Aminophenazone—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.0002	0.00221	CbGpPWpGaD
Aminophenazone—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000197	0.00217	CbGpPWpGaD
Aminophenazone—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000197	0.00217	CbGpPWpGaD
Aminophenazone—CYP17A1—Biological oxidations—POMC—multiple sclerosis	0.000196	0.00217	CbGpPWpGaD
Aminophenazone—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000194	0.00214	CbGpPWpGaD
Aminophenazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000185	0.00204	CbGpPWpGaD
Aminophenazone—CYP2C18—Metabolism—SRM—multiple sclerosis	0.000168	0.00185	CbGpPWpGaD
Aminophenazone—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000164	0.00181	CbGpPWpGaD
Aminophenazone—CYP2C18—Biological oxidations—POMC—multiple sclerosis	0.000155	0.00171	CbGpPWpGaD
Aminophenazone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000154	0.0017	CbGpPWpGaD
Aminophenazone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000154	0.0017	CbGpPWpGaD
Aminophenazone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000152	0.00168	CbGpPWpGaD
Aminophenazone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000152	0.00168	CbGpPWpGaD
Aminophenazone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00015	0.00166	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism—CYP24A1—multiple sclerosis	0.000149	0.00165	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism—CYP27B1—multiple sclerosis	0.000149	0.00165	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000146	0.00161	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism—GPC5—multiple sclerosis	0.000136	0.00151	CbGpPWpGaD
Aminophenazone—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000134	0.00148	CbGpPWpGaD
Aminophenazone—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000129	0.00143	CbGpPWpGaD
Aminophenazone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000123	0.00136	CbGpPWpGaD
Aminophenazone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000122	0.00135	CbGpPWpGaD
Aminophenazone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000122	0.00134	CbGpPWpGaD
Aminophenazone—CYP2C18—Metabolism—CYP27B1—multiple sclerosis	0.000118	0.0013	CbGpPWpGaD
Aminophenazone—CYP2C18—Metabolism—CYP24A1—multiple sclerosis	0.000118	0.0013	CbGpPWpGaD
Aminophenazone—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000114	0.00126	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism—RRM1—multiple sclerosis	0.000113	0.00125	CbGpPWpGaD
Aminophenazone—CYP3A7—Metabolism—SRM—multiple sclerosis	0.000111	0.00123	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00011	0.00122	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00011	0.00122	CbGpPWpGaD
Aminophenazone—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000109	0.0012	CbGpPWpGaD
Aminophenazone—CYP2C18—Metabolism—GPC5—multiple sclerosis	0.000108	0.00119	CbGpPWpGaD
Aminophenazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000107	0.00119	CbGpPWpGaD
Aminophenazone—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000104	0.00115	CbGpPWpGaD
Aminophenazone—CYP3A7—Biological oxidations—POMC—multiple sclerosis	0.000103	0.00114	CbGpPWpGaD
Aminophenazone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.99e-05	0.0011	CbGpPWpGaD
Aminophenazone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.91e-05	0.00109	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.85e-05	0.00109	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.85e-05	0.00109	CbGpPWpGaD
Aminophenazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	9.58e-05	0.00106	CbGpPWpGaD
Aminophenazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	9.55e-05	0.00105	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.98e-05	0.000991	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.98e-05	0.000991	CbGpPWpGaD
Aminophenazone—CYP2C18—Metabolism—RRM1—multiple sclerosis	8.95e-05	0.000987	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.77e-05	0.000968	CbGpPWpGaD
Aminophenazone—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.47e-05	0.000934	CbGpPWpGaD
Aminophenazone—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	8.1e-05	0.000894	CbGpPWpGaD
Aminophenazone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.06e-05	0.000889	CbGpPWpGaD
Aminophenazone—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	7.85e-05	0.000866	CbGpPWpGaD
Aminophenazone—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	7.85e-05	0.000866	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.68e-05	0.000847	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.68e-05	0.000847	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.54e-05	0.000831	CbGpPWpGaD
Aminophenazone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	7.47e-05	0.000824	CbGpPWpGaD
Aminophenazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	7.45e-05	0.000822	CbGpPWpGaD
Aminophenazone—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	7.3e-05	0.000806	CbGpPWpGaD
Aminophenazone—CYP3A7—Metabolism—GPC5—multiple sclerosis	7.18e-05	0.000792	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism—SRM—multiple sclerosis	6.98e-05	0.00077	CbGpPWpGaD
Aminophenazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	6.95e-05	0.000767	CbGpPWpGaD
Aminophenazone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	6.95e-05	0.000767	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.87e-05	0.000758	CbGpPWpGaD
Aminophenazone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.53e-05	0.000721	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism—BCHE—multiple sclerosis	6.5e-05	0.000716	CbGpPWpGaD
Aminophenazone—CYP2C8—Biological oxidations—POMC—multiple sclerosis	6.47e-05	0.000713	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism—SRM—multiple sclerosis	6.23e-05	0.000687	CbGpPWpGaD
Aminophenazone—CYP3A7—Metabolism—RRM1—multiple sclerosis	5.95e-05	0.000656	CbGpPWpGaD
Aminophenazone—CYP2C19—Biological oxidations—POMC—multiple sclerosis	5.77e-05	0.000637	CbGpPWpGaD
Aminophenazone—CYP2D6—Metabolism—SRM—multiple sclerosis	5.73e-05	0.000632	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism—SRM—multiple sclerosis	5.68e-05	0.000626	CbGpPWpGaD
Aminophenazone—CYP2D6—Biological oxidations—POMC—multiple sclerosis	5.31e-05	0.000586	CbGpPWpGaD
Aminophenazone—CYP2C9—Biological oxidations—POMC—multiple sclerosis	5.26e-05	0.00058	CbGpPWpGaD
Aminophenazone—CYP2C18—Metabolism—BCHE—multiple sclerosis	5.14e-05	0.000567	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	4.92e-05	0.000542	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	4.92e-05	0.000542	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism—SRM—multiple sclerosis	4.85e-05	0.000535	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.8e-05	0.00053	CbGpPWpGaD
Aminophenazone—CYP1A2—Biological oxidations—POMC—multiple sclerosis	4.5e-05	0.000496	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism—GPC5—multiple sclerosis	4.5e-05	0.000496	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	4.39e-05	0.000484	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	4.39e-05	0.000484	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.29e-05	0.000473	CbGpPWpGaD
Aminophenazone—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.12e-05	0.000454	CbGpPWpGaD
Aminophenazone—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	4.04e-05	0.000445	CbGpPWpGaD
Aminophenazone—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	4.04e-05	0.000445	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism—GPC5—multiple sclerosis	4.01e-05	0.000443	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	4e-05	0.000441	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	4e-05	0.000441	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.91e-05	0.000431	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism—APOE—multiple sclerosis	3.91e-05	0.000431	CbGpPWpGaD
Aminophenazone—CYP3A4—Metabolism—SRM—multiple sclerosis	3.74e-05	0.000413	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism—RRM1—multiple sclerosis	3.73e-05	0.000411	CbGpPWpGaD
Aminophenazone—CYP2D6—Metabolism—GPC5—multiple sclerosis	3.69e-05	0.000407	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism—GPC5—multiple sclerosis	3.66e-05	0.000404	CbGpPWpGaD
Aminophenazone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.47e-05	0.000383	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	3.42e-05	0.000377	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	3.42e-05	0.000377	CbGpPWpGaD
Aminophenazone—CYP3A7—Metabolism—BCHE—multiple sclerosis	3.42e-05	0.000377	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism—POMC—multiple sclerosis	3.36e-05	0.00037	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.34e-05	0.000369	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism—RRM1—multiple sclerosis	3.33e-05	0.000367	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism—GPC5—multiple sclerosis	3.13e-05	0.000345	CbGpPWpGaD
Aminophenazone—CYP2C18—Metabolism—APOE—multiple sclerosis	3.09e-05	0.000341	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism—ALB—multiple sclerosis	3.06e-05	0.000338	CbGpPWpGaD
Aminophenazone—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.06e-05	0.000337	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism—RRM1—multiple sclerosis	3.03e-05	0.000334	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.89e-05	0.000319	CbGpPWpGaD
Aminophenazone—CYP2C18—Metabolism—POMC—multiple sclerosis	2.66e-05	0.000293	CbGpPWpGaD
Aminophenazone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.64e-05	0.000291	CbGpPWpGaD
Aminophenazone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.64e-05	0.000291	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.59e-05	0.000286	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.58e-05	0.000285	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.48e-05	0.000274	CbGpPWpGaD
Aminophenazone—CYP2C18—Metabolism—ALB—multiple sclerosis	2.42e-05	0.000267	CbGpPWpGaD
Aminophenazone—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.41e-05	0.000266	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.35e-05	0.000259	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.26e-05	0.00025	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.22e-05	0.000244	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism—BCHE—multiple sclerosis	2.14e-05	0.000236	CbGpPWpGaD
Aminophenazone—CYP3A7—Metabolism—APOE—multiple sclerosis	2.06e-05	0.000227	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.02e-05	0.000223	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.02e-05	0.000223	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.01e-05	0.000222	CbGpPWpGaD
Aminophenazone—CYP3A4—Metabolism—RRM1—multiple sclerosis	2e-05	0.000221	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.91e-05	0.000211	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.84e-05	0.000203	CbGpPWpGaD
Aminophenazone—CYP3A7—Metabolism—POMC—multiple sclerosis	1.77e-05	0.000195	CbGpPWpGaD
Aminophenazone—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.76e-05	0.000194	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.74e-05	0.000192	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.73e-05	0.00019	CbGpPWpGaD
Aminophenazone—CYP3A7—Metabolism—ALB—multiple sclerosis	1.61e-05	0.000178	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.57e-05	0.000174	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.49e-05	0.000164	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism—APOE—multiple sclerosis	1.29e-05	0.000142	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism—APOE—multiple sclerosis	1.15e-05	0.000127	CbGpPWpGaD
Aminophenazone—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.15e-05	0.000127	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism—POMC—multiple sclerosis	1.11e-05	0.000122	CbGpPWpGaD
Aminophenazone—CYP2D6—Metabolism—APOE—multiple sclerosis	1.06e-05	0.000117	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism—APOE—multiple sclerosis	1.05e-05	0.000116	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism—ALB—multiple sclerosis	1.01e-05	0.000111	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism—POMC—multiple sclerosis	9.87e-06	0.000109	CbGpPWpGaD
Aminophenazone—CYP2D6—Metabolism—POMC—multiple sclerosis	9.08e-06	0.0001	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism—POMC—multiple sclerosis	9e-06	9.93e-05	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism—ALB—multiple sclerosis	9e-06	9.93e-05	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism—APOE—multiple sclerosis	8.95e-06	9.87e-05	CbGpPWpGaD
Aminophenazone—CYP2D6—Metabolism—ALB—multiple sclerosis	8.28e-06	9.13e-05	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism—ALB—multiple sclerosis	8.2e-06	9.05e-05	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism—POMC—multiple sclerosis	7.69e-06	8.48e-05	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism—ALB—multiple sclerosis	7.01e-06	7.73e-05	CbGpPWpGaD
Aminophenazone—CYP3A4—Metabolism—APOE—multiple sclerosis	6.91e-06	7.62e-05	CbGpPWpGaD
Aminophenazone—CYP3A4—Metabolism—POMC—multiple sclerosis	5.94e-06	6.55e-05	CbGpPWpGaD
Aminophenazone—CYP3A4—Metabolism—ALB—multiple sclerosis	5.41e-06	5.97e-05	CbGpPWpGaD
